CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Lineage Cell Therapeutics, Inc. (LCTX) on Tuesday reported a loss of $30.5 million in its second quarter.
On a per-share basis, the Carlsbad, California-based company said it had a loss of 13 cents. Losses, adjusted for asset impairment costs and non-recurring costs, came to 1 cent per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 2 cents per share.
The biotechnology company posted revenue of $2.8 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $1.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LCTX at https://www.zacks.com/ap/LCTX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
